Partially consistent with the Kaplan–Meier analysis, PGE2 and IL-6 were significant predictors of longer survival (P = 0.033 and 0.031, respectively), whereas IL-2 and IL-6 predicted tumor response to c4G12 treatment (P = 0.030 and 0.013, respectively). The gene discussed is IL2; the disease is neoplasm.